Revenue missed analyst estimates by 2.3%. Earnings per share (EPS) exceeded analyst estimates by 4.9%. Looking ahead, revenue is forecast to grow 28% p.a. on average during the next 3 years, compared ...

Q3 2024 Earnings Call Transcript November 13, 2024 Operator: Greetings, and welcome to the electroCore Third Quarter 2024 ...

Electrocore (ECOR – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Swayampakula ...

H.C. Wainwright raised the firm’s price target on electroCore (ECOR) to $22 from $15 and keeps a Buy rating on the shares after the firm ...

Researchers at New York University have devised a mathematical approach to predict the structures of crystals—a critical step in developing many medicines and electronic devices—in a matter of ...

Daniel Baker, M.D., will join Cue Biopharma's executive team as interim chief development officer (CDO), effective Monday, ...

Despite achieving its eighth consecutive record revenue quarter, electroCore Inc (ECOR) faces hurdles with net losses and ...

ElectroCore, Inc. (ECOR) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to loss of $0.68 per share a year ago. These figures ...

For the quarter ended September 30, 2024, electroCore reported net sales of $6.6 million compared to $4.5 million during the same period of 2023, which represents an approximate 45% increase over the ...

FT836 Preclinical Data Shows Robust Antigen-mediated Expansion, Functional Persistence, and Durable Anti-tumor Activity in ...

He is an expert on the Autonomic Nervous System. He is the Founder of ElectroCore, where he pioneered a non-invasive Vagus Nerve stimulator. JP has been credited as an inventor on over 250 issued ...

South Korean actor Song Jae Lim was found dead on Tuesday in his Seoul home. The South Korean hit drama returns for a second season in December. The first lady is accused of accepting a luxury ...